Company         Group
2020 2019   (R’million) Notes   2020 2019 
Restated*
      Continuing operations        
1 199,7 1 562,3   Revenue 2   29 796,1 28 578,9
      Cost of sales     (20 837,4) (19 474,7)
1 199,7 1 562,3   Gross profit     8 958,7 9 104,2
      Sales and distribution expenses     (3 899,2) (3 799,2)
      Marketing expenses     (821,2) (796,4)
(18,2) (12,9)   Other operating expenses     (1 518,5) (1 338,3)
(16,2)   Expected credit loss     (118,2)
1 165,3 1 549,4   Operating income before impairments and abnormal items 3   2 601,6 3 170,3
(1 068,4) (301,7)   Impairments and fair value losses 5   (602,9) (205,1)
3 274,0   Abnormal items 6   (90,2) 1 967,1
96,9 4 521,7   Operating income after impairments and abnormal items     1 908,5 4 932,3
(2,6)   Finance costs 7.1   (110,8) (30,2)
27,0 93,2   Finance income 7.2   14,2 30,4
(8,6) (36,5)   Foreign exchange profit/(loss) 7.3   40,1 9,6
      Investment income     15,4 12,7
      Income from associated companies 14   352,4 371,2
115,3 4 575,8   Profit before taxation     2 219,8 5 326,0
(21,3) (29,8)   Taxation 8   (726,7) (965,0)
94,0 4 546,0   Profit for the year from continuing operations     1 493,1 4 361,0
      Discontinued operations        
      Loss for the year from discontinued operations 33   (453,2) (470,2)
      Profit for the year     1 039,9 3 890,8
      Attributable to:        
94,0 4 546,0   Owners of the parent     1 014,3 3 863,3
      – Continuing operations     1 467,5 4 333,5
      – Discontinued operations     (453,2) (470,2)
      Non-controlling interest     25,6 27,5
      – Continuing operations     25,6 27,5
94,0 4 546,0         1 039,9 3 890,8
      Basic earnings per ordinary share (cents)     612,2 2 332,6
      – Continuing operations     885,7 2 616,5
      – Discontinued operations     (273,5) (283,9)
      Diluted basic earnings per ordinary share (cents)     607,5 2 325,3
      – Continuing operations     879,0 2 608,3
      – Discontinued operations     (271,5) (283,0)
      Headline earnings per share is disclosed in note 9        
* Restated as required by IFRS 5 in relation to the treatment of Value Added Meat Products (VAMP), a division of Tiger Consumer Brands Limited (Domestic operations – Consumer Brands – Food) as a discontinued operation. Refer to note 33.